 Tomography, Optical Coherence
"Tomography, Optical Coherence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An imaging method using LASERS that is used for mapping subsurface structure. When a reflective site in the sample is at the same optical path length (coherence) as the reference mirror, the detector observes interference fringes.
| Descriptor ID |
D041623
|
| MeSH Number(s) |
E01.370.350.589.249.500 E01.370.350.825.805.500 E05.642.249.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tomography, Optical Coherence".
Below are MeSH descriptors whose meaning is more specific than "Tomography, Optical Coherence".
This graph shows the total number of publications written about "Tomography, Optical Coherence" by people in this website by year, and whether "Tomography, Optical Coherence" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 | | 2006 | 0 | 2 | 2 | | 2007 | 0 | 1 | 1 | | 2008 | 2 | 1 | 3 | | 2009 | 3 | 1 | 4 | | 2010 | 2 | 1 | 3 | | 2012 | 1 | 3 | 4 | | 2013 | 3 | 4 | 7 | | 2014 | 1 | 5 | 6 | | 2015 | 2 | 3 | 5 | | 2016 | 7 | 7 | 14 | | 2017 | 4 | 4 | 8 | | 2018 | 6 | 1 | 7 | | 2019 | 5 | 8 | 13 | | 2020 | 1 | 8 | 9 | | 2021 | 3 | 3 | 6 | | 2022 | 1 | 7 | 8 | | 2023 | 0 | 7 | 7 | | 2024 | 4 | 3 | 7 | | 2025 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Tomography, Optical Coherence" by people in Profiles.
-
Li Y, Komatsu C, He L, Miller MR, Noori J, van der Merwe Y, Ho LC, Rosner IA, Barnett JM, Jabbari K, Wollstein G, Bilonick RA, Fu VLN, Solari MG, Su AA, Chan KC, Schuman JS, Washington KM. Surgical techniques and outcome assessment of a novel vascularized orthotopic rodent whole eye transplantation model. PLoS One. 2025; 20(5):e0311392.
-
Chen H, Strong Caldwell A, Patnaik JL, Feinstein EG, Ghiassi M, Mathias MT, Oliver SCN. LONG-TERM FUNCTIONAL AND CLINICAL OUTCOMES IN FAMILIAL EXUDATIVE VITREORETINOPATHY. Retina. 2025 May 01; 45(5):908-914.
-
Gnanaraj R, Lisker-Cervantes A, Patnaik J, Rajeswaren V, Mehta N, Gange W, Lynch AM, Palestine A, Mathias M, Manoharan N, Mandava N, Forest TEC. Multimodal imaging biomarkers for progression from intermediate to advanced age-related macular degeneration (AMD): a 10-year prospective longitudinal cohort study from the University of Colorado AMD registry. BMJ Open Ophthalmol. 2025 Apr 05; 10(1).
-
Liu J, Edwards Mayhew RG, Imbornoni LM, Jung JL, Oliver SCN, Foreman NK, Mulcahy Levy JM, Hemenway M, McCourt EA. Pediatric MEK inhibitor-associated retinopathy: 8-year experience at a tertiary academic center and report of 2 cases. J AAPOS. 2025 Apr; 29(2):104178.
-
Stein EJ, Mesenbring E, Smith T, Hebbe A, Salahuddin T, Waldo SW, Dyal MD, Doll JA. Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2025 Feb; 18(2):e014528.
-
Kang C, Lo JE, Zhang H, Ng SM, Lin JC, Scott IU, Kalpathy-Cramer J, Liu SA, Greenberg PB. Artificial intelligence for diagnosing exudative age-related macular degeneration. Cochrane Database Syst Rev. 2024 10 17; 10:CD015522.
-
Borchert GA, Kiire CA, Stone NM, Akil H, Gkika T, Fischer MD, Xue K, Cehajic-Kapetanovic J, MacLaren RE, Charbel Issa P, Downes SM, De Silva SR. Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema. Eye (Lond). 2024 Dec; 38(18):3569-3577.
-
Sundararajan M, Rathinam SR, Thundikandy R, Kanakath A, Balamurugan S, Vedhanayaki R, Miller DC, Lim LL, Suhler EB, Al-Dhibi HA, Arellanes-Garcia L, Reddy AK, Feng S, Doan T, Porco TC, Shantha JG, Acharya NR, Gonzales JA. Association Between Baseline Macular Morphologic Features on Optical Coherence Tomography and Visual Outcomes in Patients with Vogt-Koyanagi-Harada Disease. Ocul Immunol Inflamm. 2025 Feb; 33(2):263-270.
-
Lisker-Cervantes A, Gill Z, Gnanaraj R, Rajeswaren V, Mehta N, Gange B, Patnaik JL, Lynch AM, Palestine AG, Mathias M, Manoharan N, Mandava N, de Carlo Forest TE. Differences in imaging biomarkers between patients with intermediate and advanced non-neovascular age-related macular degeneration (AMD) in the University of Colorado AMD registry. Eur J Ophthalmol. 2025 Jan; 35(1):276-282.
-
de Carlo Forest TE, Gill Z, Lisker-Cervantes A, Gnanaraj R, Grove N, Patnaik JL, Lynch AM, Palestine AG, Mathias M, Manoharan N, Mandava N. Association Between Quantitative and Qualitative Imaging Biomarkers and Geographic Atrophy Growth Rate. Am J Ophthalmol. 2024 08; 264:168-177.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|